Lysosome

Feb 10, 2020

Takeda to Present Research Advances in Rare Lysosomal Storage Disorders at 16th Annual WORLDSymposium(TM) 2020

Jan 20, 2020

Polaryx Therapeutics Receives IND Approval for PLX-200 From the FDA for the Treatment of Late Infantile Neuronal Ceroid Lipofuscinosis

Dec 23, 2019

Polaryx Therapeutics Submits Investigational New Drug Application to the U.S. FDA for the Treatment of Late Infantile Neuronal Ceroid Lipofuscinosis With PLX-200

Nov 07, 2019

Arkuda Therapeutics Closes $44M Series A Financing to Advance Novel Medicines Targeting Progranulin and Lysosomal Biology to Treat Neurodegenerative Diseases

Nov 27, 2018

15th Annual WORLDSymposium 2019 Scientific Meeting February 4 - 8, 2019 Preliminary Program Announced

Nov 12, 2018

Late-Breaking Abstract Submissions Are Now Open for the 15th Annual WORLDSymposium 2019 Research Conference in Orlando, Florida, USA

Aug 23, 2018

E-Scape Bio Appoints Biopharma Industry Veteran Julie Anne Smith As President and Chief Executive Officer

Aug 15, 2018

Perlara announces Glycogen Storage Diseases PerlQuest with the University of Notre Dame

Jun 12, 2018

E-Scape Bio Obtains Worldwide Rights from AbbVie for Selective S1P5 Program Targeting CNS-related Lysosomal Storage Disorders

Aug 03, 2017

Lysosomal Storage Disorder Therapeutics Pipeline Analysis 2017